Suan, Rhex R.
HRN: 25-84-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2024
OXACILLIN 500MG (VIAL)
11/11/2024
11/18/2024
IV
80mg
Q6hours
T/c Mastoid Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes